Cargando…
Response to the letter to the Editor “Regional citrate anticoagulation for intermittent hemodialysis in the intensive care. What is the optimal set-up?” by Gubensek et al.
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093332/ https://www.ncbi.nlm.nih.gov/pubmed/33939037 http://dx.doi.org/10.1186/s13613-021-00859-9 |
_version_ | 1783687789345243136 |
---|---|
author | Leroy, Christophe Lautrette, Alexandre |
author_facet | Leroy, Christophe Lautrette, Alexandre |
author_sort | Leroy, Christophe |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8093332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-80933322021-05-06 Response to the letter to the Editor “Regional citrate anticoagulation for intermittent hemodialysis in the intensive care. What is the optimal set-up?” by Gubensek et al. Leroy, Christophe Lautrette, Alexandre Ann Intensive Care Letter to the Editor Springer International Publishing 2021-05-03 /pmc/articles/PMC8093332/ /pubmed/33939037 http://dx.doi.org/10.1186/s13613-021-00859-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Letter to the Editor Leroy, Christophe Lautrette, Alexandre Response to the letter to the Editor “Regional citrate anticoagulation for intermittent hemodialysis in the intensive care. What is the optimal set-up?” by Gubensek et al. |
title | Response to the letter to the Editor “Regional citrate anticoagulation for intermittent hemodialysis in the intensive care. What is the optimal set-up?” by Gubensek et al. |
title_full | Response to the letter to the Editor “Regional citrate anticoagulation for intermittent hemodialysis in the intensive care. What is the optimal set-up?” by Gubensek et al. |
title_fullStr | Response to the letter to the Editor “Regional citrate anticoagulation for intermittent hemodialysis in the intensive care. What is the optimal set-up?” by Gubensek et al. |
title_full_unstemmed | Response to the letter to the Editor “Regional citrate anticoagulation for intermittent hemodialysis in the intensive care. What is the optimal set-up?” by Gubensek et al. |
title_short | Response to the letter to the Editor “Regional citrate anticoagulation for intermittent hemodialysis in the intensive care. What is the optimal set-up?” by Gubensek et al. |
title_sort | response to the letter to the editor “regional citrate anticoagulation for intermittent hemodialysis in the intensive care. what is the optimal set-up?” by gubensek et al. |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093332/ https://www.ncbi.nlm.nih.gov/pubmed/33939037 http://dx.doi.org/10.1186/s13613-021-00859-9 |
work_keys_str_mv | AT leroychristophe responsetothelettertotheeditorregionalcitrateanticoagulationforintermittenthemodialysisintheintensivecarewhatistheoptimalsetupbygubenseketal AT lautrettealexandre responsetothelettertotheeditorregionalcitrateanticoagulationforintermittenthemodialysisintheintensivecarewhatistheoptimalsetupbygubenseketal |